PQI in Action: Nirogacestat use in Management of Adults with Progressing Desmoid Tumors
Date: Friday, March 6
Time: 2 pm EST
Featuring: Astrid Slaughter, PharmD, PhD, BCSCP, BCOP & Elizabeth Dennis, MSN, APRN, FNP-C | Texas Oncology
Desmoid tumors are rare, but the care is rarely simple. In this webinar, we’ll use NCODA’s PQI in Action resource on nirogacestat as a practical guide for medically integrated teams supporting adults who require systemic therapy. With perspectives from Texas Oncology, we’ll focus on what matters in real workflows, from patient selection and therapy goals to monitoring, side effect management, and access support that helps patients stay on treatment.
What we’ll cover:
- Desmoid tumor basics, plus the mechanism of action and efficacy data behind nirogacestat for adults who require systemic therapy
- Patient selection considerations and therapy goals when initiating nirogacestat
- Recommended dosing, dose modification strategies, and monitoring parameters to support safety and treatment continuity
- Evidence-based adverse event management, patient education, and financial navigation strategies to support safe and effective use in clinical practice
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Additional Upcoming Webinars
Upcoming Webinar
PQI in Action: Nirogacestat use in Management of Adults with Progressing Desmoid Tumors
March 6, 2026 | 2:00 PM
Upcoming Webinar
Educational & Equity Implications of Biomarker Testing & Targeted Therapy Access in NSCLC
March 9, 2026 | 2:00 PM